- 2021
-
Press releases - 21.10.2021
COVID-19: How Does SARS-CoV-2 Infection Affect Vascular Irrigation of the Brain?
A large number of researchers are currently mobilized to increase knowledge of SARS-CoV-2 in order to improve the treatment of infected patients and try to predict the future health impacts of infection with the virus. Researchers have been the first to identify a direct effect of SARS-CoV-2 on the brain’s blood vessels.
-
Press releases - 21.10.2021
Découverte de nouveaux marqueurs génétiques à l’origine d’une maladie des artères essentiellement féminine
La dysplasie fibromusculaire artérielle (DFM) est une anomalie de la paroi de certaines artères entraînant une augmentation du risque cardiovasculaire chez les personnes qui en sont atteintes. 3% de la population générale pourrait en être affectée et au moins 80% des personnes atteintes de cette maladie sont des femmes. Des chercheurs sont parvenus à décrire la composante génétique de la maladie, premier par vers l’identification de nouvelles cibles thérapeutiques.
-
Press releases - 15.10.2021
Towards the elimination of cholera in Haiti
In 2013, a medical team proposed to the Haitian government and to Unicef a coordinated strategy to fight against cholera, aimed at breaking the chains of transmission. This strategy and its results, which show the apparent cessation of cholera transmission in Haiti since 2019, have just been the subject of a publication in the journal Emerging Infectious Diseases.
-
Press releases - 13.10.2021
Study on the role of “ceramides” in infection by SARS-CoV-2 which could constitute a biomarker of severity and a therapeutic target in the management of Covid-19
Teams of researchers published on October 4, 2021 in the journal Molecular Psychiatry (Nature Publishing Group) a summary of the results of the international literature on the central role that “ ceramides ”, a class of lipids, may play a role in SARS-CoV-2 infection.
-
Press releases - 12.10.2021
Good tolerance of the BNT162b2 vaccine (Pfizer / BioNTech) and good efficacy of the immune response against SARS-CoV-2 variants in patients with systemic lupus
Teams of researchers measured the antibody and cellular responses generated by a messenger RNA vaccine in patients with systemic lupus (LS). This work shows that vaccination is both well tolerated and effective, even against worrying variants. The factors associated with a poor vaccine response in some of these patients have been identified in order to better anticipate who should benefit from reinforced protective measures and / or adapted vaccine protocols.
-
Press releases - 07.10.2021
Lancement du portail appelsprojetsrecherche.fr
Afin de faciliter l’accès aux appels à projets et aux financements associés de la recherche, l’ADEME, l’ANR, l’Inserm dont l’ANRS | Maladies infectieuses émergentes, l’Anses et l’INCa regroupent l’ensemble de leurs appels à projets scientifiques sur un portail unique : appelsprojetsrecherche.fr.
-
Press releases - 06.10.2021
New therapeutic perspectives for patients with lymphatic abnormalities linked to a mutation in the PIK3CA gene
The team of the adult nephrology-renal transplantation department of the Necker-Enfants Malades AP-HP hospital, Inserm and the University of Paris has carried out work, coordinated by Prof. Guillaume Canaud, which opens up new perspectives. therapies for patients with lymphatic abnormalities linked to a mutation in the PIK3CA gene.
-
Press releases - 30.09.2021
Regenerating Lost Neurons: A Successful Bet for Research
How can lost neurons be regenerated? Using an animal model of epilepsy, the researchers have succeeded in transforming non-neuronal cells in the brain into new inhibitory neurons that reduce chronic epileptic activity by half. This research will in time make it possible to envisage a therapeutic application of this strategy.
-
Press releases - 28.09.2021
Inserm Publishes Book on Fake News Making Rigorous and Credible Health Information Accessible to All
As the effects of the COVID-19 crisis continue to make themselves felt, how do we answer the many health questions raised by citizens and make space for scientific information that is useful in everyday life? More motivated than ever to provide robust scientific information to all, Inserm has joined forces with publisher Le Cherche-Midi to deconstruct fake news and preconceived ideas regarding our health.
-
Press releases - 21.09.2021
Covid-19 : identification de cellules immunitaires associées à la survie dans les formes sévères de la maladie
Since the pandemic began, many studies have tried to explain what differentiates the immune response of people with severe forms of COVID-19 resulting in death from that of other patients. In a new study, researchers from Inserm and Sorbonne Université at the Center for Immunology and Infectious Diseases, in collaboration with physician researchers from Paris hospitals group AP-HP, focused on a type of immune response known as the cellular immune response.